238 related articles for article (PubMed ID: 5074330)
1. The application of an in vitro cytotoxicity test to studies of the effects of drugs on the cellular immune response in mice. I. Primary response.
Fass L; Fefer A
J Immunol; 1972 Oct; 109(4):749-53. PubMed ID: 5074330
[No Abstract] [Full Text] [Related]
2. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Einstein AB; Fass L; Fefer A
Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice.
Lamon EW; Gatti RA; Kiessling R; Fenyö EM
Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367
[TBL] [Abstract][Full Text] [Related]
4. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
Fass L; Fefer A
Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
[No Abstract] [Full Text] [Related]
5. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
Harada M; Pearson G; Pettigrew H; Redmon L; Orr T
Cancer Res; 1973 Nov; 33(11):2886-93. PubMed ID: 4583975
[No Abstract] [Full Text] [Related]
6. Cell-mediated cell lysis in vitro: genetic control of killer cell production and target specificities in the mouse.
Nabholz M; Vives J; Young HM; Meo T; Miggiano V; Rijnbeek A; Shreffler DC
Eur J Immunol; 1974 May; 4(5):378-87. PubMed ID: 4277395
[No Abstract] [Full Text] [Related]
7. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
MacDonald HR; Phillips RA; Miller RG
J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
[No Abstract] [Full Text] [Related]
8. Serologic analysis of tumor-associated surface antigens on a Moloney leukemia virus-induced lymphoma, MBL-2.
Ng AK; McIntire R; Holden HT; Herberman RB
J Immunol; 1978 Sep; 121(3):856-62. PubMed ID: 690439
[No Abstract] [Full Text] [Related]
9. Differential regulatory effects of accessory cells on the generation of cell-mediated immune reactions.
Miller CL; Mishell RI
J Immunol; 1975 Feb; 114(2 Pt 1):692-5. PubMed ID: 1091702
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immunity to Friend virus-induced leukemia.
Ting CC; Shiu G; Rodrigues D; Herberman RB
Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
[No Abstract] [Full Text] [Related]
11. Treatment of a Moloney lymphoma with cyclophosphamide and H-2-incompatible spleen cells.
Fefer A
Cancer Res; 1973 Apr; 33(4):641-4. PubMed ID: 4696464
[No Abstract] [Full Text] [Related]
12. Effect of immune factors on the motility of lymphoma cells.
Cochran AJ; Klein E; Keissling R
J Natl Cancer Inst; 1972 Jun; 48(6):1657-61. PubMed ID: 4560294
[No Abstract] [Full Text] [Related]
13. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
Fujimoto S; Chen CH; Sabbadini E; Sehon AH
J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
[No Abstract] [Full Text] [Related]
14. Modulation of the immune response to transplantation antigens. I. The effects of immunization using adjuvants on the immune response of mice to a tumour allograft.
Zola H
Clin Exp Immunol; 1972 Aug; 11(4):585-93. PubMed ID: 4563711
[TBL] [Abstract][Full Text] [Related]
15. Studies on the FMR antigen.
Lilly F; Nathenson SG
Transplant Proc; 1969 Mar; 1(1):85-9. PubMed ID: 4332534
[No Abstract] [Full Text] [Related]
16. Selective impairment of cell antigenicity by fixation.
Gatti RA; Ostborn A; Fagraeus A
J Immunol; 1974 Oct; 113(4):1361-8. PubMed ID: 4213372
[No Abstract] [Full Text] [Related]
17. Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test.
Shiku H; Bean MA; Old LJ; Oettgen HF
J Natl Cancer Inst; 1975 Feb; 54(2):415-25. PubMed ID: 1113324
[TBL] [Abstract][Full Text] [Related]
18. Role of macrophages in tumour immunity. II. Involvement of a macrophage cytophilic factor during syngeneic tumour growth inhibition.
Evans R; Alexander P
Immunology; 1972 Oct; 23(4):627-36. PubMed ID: 4563478
[TBL] [Abstract][Full Text] [Related]
19. Tumor immunity to murine plasma cell tumours. Influence of responder genotype on the specificity of the immune response to plasmacytomas and T lymphomas.
Burton RC; Warner NL
Aust J Exp Biol Med Sci; 1978 Oct; 56(5):587-95. PubMed ID: 751633
[TBL] [Abstract][Full Text] [Related]
20. Immune response to Gross virus-induced lymphoma. 3. Characteristics of the cellular immune response.
De Landazuri MO; Herberman RB
J Natl Cancer Inst; 1972 Jul; 49(1):147-54. PubMed ID: 5037432
[No Abstract] [Full Text] [Related]
[Next] [New Search]
